Poolbeg Pharma plc (LON:POLB) has announced its audited results for the period ended 31 December 2021. These results follow the Company’s spin-out from Open Orphan plc and the subsequent listing on the AIM market of the London Stock Exchange in July 2021. Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company with a capital light model which … Continue reading Poolbeg Pharma makes excellent progress post IPO and momentum building